• Register
  • Login
  • Subscribe
  • Contact Us

Contrast - 74% Non-ionic 350 - 50ml; Contrast - Ioversol 74% Naionico 350 - 100ml

BrazilTenders notice for Contrast - 74% Non-ionic 350 - 50ml; Contrast - Ioversol 74% Naionico 350 - 100ml. The reference ID of the tender is 64101673 and it is closing on 09 Mar 2022.

Tender Details

  • Country: Brazil
  • Summary: Contrast - 74% Non-ionic 350 - 50ml; Contrast - Ioversol 74% Naionico 350 - 100ml
  • BRT Ref No: 64101673
  • Deadline: 09 Mar 2022
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: PE-RP 146 /2022
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • Contrast - 74% non-ionic 350 - 50ml; Contrast - IOVERSOL 74% Naionico 350 - 100ml
    Executive exposure: 365 days Opening of the session: 03/09/2022 Time: 0900 am
    Items composition:
    Sequence - Summary Description - Unit of Measurement - Quantity
    1 - 1.1 IOVERSOL 741 mg / ml (equivalent to 350 mg / ml iodine), pharmaceutical form of injectable solution, ampoule / vial-ampaulk / syringe filled, intravenous or Iopromide administration 768.86 mg / ml = 370 mg / ml), pharmaceutical form Injectable solution, presentation form of ampoule vial, intravenous administration or yeexol 755 mg / ml (equivalent to 350 mg / ml iodine), pharmaceutical form of injectable solution, ampule / fragrance presentation form / Filled syringe, intravenous / intracavitary / oral administration or Iopamidol 755 mg / ml (equivalent to 370 mg / ml iodine), pharmaceutical form of injectable solution, form of ampoule / fragrant presentation / syringe filled, intravenous administration - unit 50,00 mililiter - 3192
    2 - 1.2 ioversol 741 mg / ml (equivalent to 350 mg / ml iodine), pharmaceutical form Injectable solution, ampoule / fry presentation form ...
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Contrast - 74% Non-ionic 350 - 50ml; Contrast - Ioversol 74% Naionico 350 - 100ml - Brazil Tender

The MEDICAL ASSISTANCE INSTITUTE FOR THE STATE PUBLIC SERVER - IAMSPE, a Government sector organization in Brazil, has announced a new tender for Contrast - 74% Non-ionic 350 - 50ml; Contrast - Ioversol 74% Naionico 350 - 100ml. This tender is published on BrazilTenders under BRT Ref No: 64101673 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-03-09.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

BrazilTenders Features

BrazilTenders Features

Fresh and verified Tenders from Brazil. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting BrazilTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Brazil in your email inbox.

  Chat with us